The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

E-therapeutics Share News (ETX)

E-therapeutics Information

Buy ETX Shares
Add ETX to Watchlist
Add ETX to Alert

Share Price Information for E-therapeutics (ETX)

London Stock Exchange

Share Price is delayed by 15 minutes

Share Price: 9.40

Bid: 9.00

Ask: 9.35

Change: -0.625 (-6.38%)

Spread: 0.35 (3.889%)

Open: 9.45

High: 9.60

Low: 9.40

Prev. Close: 9.80

ETX Live Price

Last checked at -

IN BRIEF: e-Therapeutics Bags GBP750,000 From Retail Offer

Wed, 08th Jul 2020 16:21

e-Therapeutics PLC - Oxford-based drug discovery platform - Raises GBP750,000 in retail offer as part of GBP12.4 million fundraise announced on Tuesday.

Current stock price: 12.87 pence

Year-to-date change: up more than fivefold from 3.10p

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News

20 Mar 2018 16:14

UK Earnings, Trading Statements Calendar - Next 7 Days

Wednesday 21 March KingfisherFull Year ResultsAlpha FXFull Year In SportFull 22

9 Jan 2017 08:49

E-Therapeutics Hires Amgen Director As New Chief Executive

6 Oct 2016 11:23

DIRECTOR DEALINGS: e-Therapeutics Non-Executive Acquires Shares

14 Sep 2016 11:23

e-Therapeutics Development Director Steve Self To Step Down

13 Jul 2016 09:13

E-Therapeutics Chairman Takes On Executive Duties As CEO Steps Down

1 Jun 2016 08:03

e-Therapeutics Offer For Searchbolt Now Wholly Unconditional

25 May 2016 08:18

e-Therapeutics Focused On Validation Of Drug Discovery Platform

18 May 2016 15:05

AGM, EGM Calendar - Week Ahead

12 May 2016 11:13

DIRECTOR DEALINGS: E-Therapeutics Non-Executive Acquires Shares

11 May 2016 09:06

e-Therapeutics To Buy Searchbolt For GBP2.3 Million (ALLISS)

22 Mar 2016 11:40

E-Therapeutics Loss Widens As Active Projects Increase

15 Mar 2016 16:15

Earnings, Trading Statements Calendar - Week Ahead

15 Feb 2016 10:43

WINNERS & LOSERS SUMMARY: Reckitt Benckiser Results Please Investors

15 Feb 2016 09:45

E-Therapeutics depression drug trials miss targets

(ShareCast News) - Drug trials results for e-Therapeutics' depression treatment were not as successful as had been hoped, sending shares in the company sharply lower. Phase IIb clinical trials of the company's ETS6103 product did not achieve the aim of matching the efficacy of existing tricyclic ant

15 Feb 2016 08:20

E-Therapeutics Shares Drop As ETS6103 Trials Miss Primary Endpoint